Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akari Murata

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Biochemical and Biophysical Research Communications|June 24, 2023
Electrical pulse stimulation-induced tetanic exercise simulation increases the secretion of extracellular vesicles from C2C12 myotubesAkari Murata, Hirokazu Akiyama, Hiroyuki Honda, et al.
BMJ Case Reports|February 14, 2018
Successful treatment of non-tuberculous mycobacterial pleurisy with acute fever by antimycobacterial therapyMako Yamoto, Yukio Kawagishi, Akari Murata, et al.
Breast Cancer : Basic and Clinical Research|November 26, 2024
The Histopathology of Abemaciclib-Induced Interstitial Lung Disease: A First Case Report With Transbronchial Lung CryobiopsyShota Kaburaki, Toru Tanaka, Akari Murata, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Long-lasting shrinkage in tumor mass after discontinuation of nivolumab treatmentHideharu Kimura, Takashi Sone, Akari Murata, et al.
Translational Lung Cancer Research|April 23, 2021
Late-onset programmed cell death protein-1 inhibitor-induced pneumonitis after cessation of nivolumab or pembrolizumab in patients with advanced non-small cell lung cancer: a case seriesHideharu Kimura, Takashi Sone, Tomoyuki Araya, et al.
Advanced Biosystems|October 21, 2020
In Vitro Model of Human Skeletal Muscle Tissues with Contractility Fabricated by Immortalized Human Myogenic CellsTakunori Nagashima, Stacy Hadiwidjaja, Saki Ohsumi, et al.
Respiratory Medicine|November 29, 2021
Kinetic changes in serum KL-6 levels predict disease progression in patients with systemic sclerosis-associated interstitial lung diseaseSatoshi Watanabe, Kazumasa Kase, Keigo Saeki, et al.
Journal of Thoracic Disease|August 23, 2021
Fractional analysis of bronchoalveolar lavage in systemic sclerosis-associated interstitial lung diseaseKazumasa Kase, Satoshi Watanabe, Keigo Saeki, et al.
Oncotargets and Therapy|June 29, 2023
Remarkable Clinical Response of <i>ALK</i>-Rearranged/<i>TP53</i>-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case ReportHirokazu Iso, Akihiko Miyanaga, Naohiro Kadoma, et al.
Journal of Thoracic Disease|April 3, 2018
Lung cancer in connective tissue disease-associated interstitial lung disease: clinical features and impact on outcomesSatoshi Watanabe, Keigo Saeki, Yuko Waseda, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biochemical and Biophysical Research Communications|June 24, 2023
Electrical pulse stimulation-induced tetanic exercise simulation increases the secretion of extracellular vesicles from C2C12 myotubesAkari Murata, Hirokazu Akiyama, Hiroyuki Honda, et al.
BMJ Case Reports|February 14, 2018
Successful treatment of non-tuberculous mycobacterial pleurisy with acute fever by antimycobacterial therapyMako Yamoto, Yukio Kawagishi, Akari Murata, et al.
Breast Cancer : Basic and Clinical Research|November 26, 2024
The Histopathology of Abemaciclib-Induced Interstitial Lung Disease: A First Case Report With Transbronchial Lung CryobiopsyShota Kaburaki, Toru Tanaka, Akari Murata, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Long-lasting shrinkage in tumor mass after discontinuation of nivolumab treatmentHideharu Kimura, Takashi Sone, Akari Murata, et al.
Translational Lung Cancer Research|April 23, 2021
Late-onset programmed cell death protein-1 inhibitor-induced pneumonitis after cessation of nivolumab or pembrolizumab in patients with advanced non-small cell lung cancer: a case seriesHideharu Kimura, Takashi Sone, Tomoyuki Araya, et al.
Advanced Biosystems|October 21, 2020
In Vitro Model of Human Skeletal Muscle Tissues with Contractility Fabricated by Immortalized Human Myogenic CellsTakunori Nagashima, Stacy Hadiwidjaja, Saki Ohsumi, et al.
Respiratory Medicine|November 29, 2021
Kinetic changes in serum KL-6 levels predict disease progression in patients with systemic sclerosis-associated interstitial lung diseaseSatoshi Watanabe, Kazumasa Kase, Keigo Saeki, et al.
Journal of Thoracic Disease|August 23, 2021
Fractional analysis of bronchoalveolar lavage in systemic sclerosis-associated interstitial lung diseaseKazumasa Kase, Satoshi Watanabe, Keigo Saeki, et al.
Oncotargets and Therapy|June 29, 2023
Remarkable Clinical Response of <i>ALK</i>-Rearranged/<i>TP53</i>-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case ReportHirokazu Iso, Akihiko Miyanaga, Naohiro Kadoma, et al.
Journal of Thoracic Disease|April 3, 2018
Lung cancer in connective tissue disease-associated interstitial lung disease: clinical features and impact on outcomesSatoshi Watanabe, Keigo Saeki, Yuko Waseda, et al.
Pageof 2